Angina pectoris and silent ischemia in the elderly: a management update.
Coronary artery disease accompanied by symptomatic and asymptomatic myocardial ischemia is a common entity in older patients. The pathophysiology of myocardial ischemia is related to an imbalance in myocardial demand and coronary perfusion. Treatment strategies for symptomatic myocardial ischemia include correction of aggravating medical conditions (eg, anemia or hypertension) and the use of nitrates, beta-adrenergic blockers, salicylates, and calcium-entry blockers, alone or in combination. Silent myocardial ischemia is also a prevalent condition in older individuals, with and without angina pectoris. Treatment regimens are similar to those used in symptomatic patients.
Albert Einstein College of Medicine, Bronx, NY.
E J
EJ
Lazar
J M
JM
Lazar
W
W
Frishman
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D002985:Clinical Protocols / Q000592:standards; D003327:Coronary Disease / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D004359:Drug Therapy, Combination; D005853:Geriatrics / Q000379:methods*; D006305:Health Status Indicators; D006801:Humans; D009566:Nitrates / Q000494:pharmacology / Q000627:therapeutic use*; D011379:Prognosis; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D009566:Nitrates